These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34989136)

  • 1. microRNAs and long non-coding RNAs as biomarkers for polycystic ovary syndrome.
    Tamaddon M; Azimzadeh M; Tavangar SM
    J Cell Mol Med; 2022 Feb; 26(3):654-670. PubMed ID: 34989136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis.
    Mu L; Sun X; Tu M; Zhang D
    Reprod Biol Endocrinol; 2021 Jan; 19(1):10. PubMed ID: 33446212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome.
    Jiao J; Shi B; Wang T; Fang Y; Cao T; Zhou Y; Wang X; Li D
    Hum Reprod; 2018 Sep; 33(9):1735-1748. PubMed ID: 30052945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review.
    Nasser JS; Altahoo N; Almosawi S; Alhermi A; Butler AE
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs as a piece of polycystic ovary syndrome puzzle.
    Abolghasemi M; Mahjoub S
    Mol Biol Rep; 2021 Apr; 48(4):3845-3851. PubMed ID: 33993404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune dysfunction mediated by the competitive endogenous RNA network in fetal side placental tissue of polycystic ovary syndrome.
    Xie N; Wang F; Chen D; Zhou J; Xu J; Qu F
    PLoS One; 2024; 19(3):e0300461. PubMed ID: 38512862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of mRNA and long noncoding RNA in the ovaries of letrozole-induced polycystic ovary syndrome rat model through deep sequencing.
    Fu LL; Xu Y; Li DD; Dai XW; Xu X; Zhang JS; Ming H; Zhang XY; Zhang GQ; Ma YL; Zheng LW
    Gene; 2018 May; 657():19-29. PubMed ID: 29505837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study.
    Sun X; Liu Y; Gao X; Du M; Gao M; Zhong X; Wei X
    Front Immunol; 2021; 12():669819. PubMed ID: 33936113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs related to androgen metabolism and polycystic ovary syndrome.
    Sørensen AE; Udesen PB; Wissing ML; Englund ALM; Dalgaard LT
    Chem Biol Interact; 2016 Nov; 259(Pt A):8-16. PubMed ID: 27270454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis.
    Deswal R; Dang AS
    Fertil Steril; 2020 Mar; 113(3):661-669.e2. PubMed ID: 32192599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients.
    Huang X; Hao C; Bao H; Wang M; Dai H
    J Assist Reprod Genet; 2016 Jan; 33(1):111-21. PubMed ID: 26650608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review.
    Abdalla M; Deshmukh H; Atkin SL; Sathyapalan T
    Life Sci; 2020 Oct; 259():118174. PubMed ID: 32745529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome.
    Chen Z; Ou H; Wu H; Wu P; Mo Z
    DNA Cell Biol; 2019 Aug; 38(8):754-762. PubMed ID: 31305133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a ceRNA-based lncRNA-mRNA network to identify functional lncRNAs in polycystic ovarian syndrome.
    Ma Y; Ma L; Cao Y; Zhai J
    Aging (Albany NY); 2021 Mar; 13(6):8481-8496. PubMed ID: 33714202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Marks in Polycystic Ovary Syndrome.
    Motta AB
    Curr Med Chem; 2020; 27(39):6727-6743. PubMed ID: 31580245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome.
    Jing T; Wu Y; Wan A; Ge C; Chen ZJ; Du Y
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of MiRNA in polycystic ovary syndrome (PCOS).
    Chen B; Xu P; Wang J; Zhang C
    Gene; 2019 Jul; 706():91-96. PubMed ID: 31054362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and analysis of a lncRNA (PWRN2)-mediated ceRNA network reveal its potential roles in oocyte nuclear maturation of patients with PCOS.
    Huang X; Pan J; Wu B; Teng X
    Reprod Biol Endocrinol; 2018 Aug; 16(1):73. PubMed ID: 30075721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whispers of the polycystic ovary syndrome theater: Directing role of long noncoding RNAs.
    Lin X; Nie X; Deng P; Wang L; Hu C; Jin N
    Noncoding RNA Res; 2024 Dec; 9(4):1023-1032. PubMed ID: 39022674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS).
    Heidarzadehpilehrood R; Pirhoushiaran M
    Noncoding RNA Res; 2024 Jun; 9(2):624-640. PubMed ID: 38571815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.